Sort by
Refine Your Search
-
Listed
-
Country
- United States
- Germany
- Denmark
- United Kingdom
- France
- Belgium
- Sweden
- Luxembourg
- Canada
- Mexico
- Australia
- Italy
- Spain
- Singapore
- Austria
- India
- South Africa
- Finland
- Norway
- Portugal
- Hong Kong
- Ireland
- Argentina
- Czech Republic
- Japan
- Netherlands
- Qatar
- Saudi Arabia
- Slovenia
- Switzerland
- Worldwide
- 21 more »
- « less
-
Program
-
Field
-
of the world's top universities and a founding member of the Francis Crick Institute. The Institute draws together over 400 scientists working together to develop world-class basic and translational cancer
-
. superlattices) this architecture has unparalleled scope for quantum property design. Your particular focus will be on developing a novel characterisation platform that allows fully functional devices to be
-
Position Details School of Biosciences Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally in the range £36,130 to £45,413 with potential progression
-
development and/or public engagement activities of manifest benefit to the College and the University, often under supervision of a project leader Collect research data; this may be through a variety of
-
proteins with regard to their role in the development of cancer, the emergence of therapy resistance, as predictive markers to guide therapy and as therapeutic targets. Your Responsibilities Independent
-
this project, we will further collaborate with the metabolomic facility. IRCCS Humanitas Research Hospital: is a highly specialised research and university hospital. It is the first Italian hospital certified
-
by EU Horizon RIA with partners in Denmark, Germany, and France. You will be part of our team aiming to develop and utilize advanced X-ray techniques in the ultrafast time domain (femtoseconds
-
represents a unique opportunity to pioneer the development of organ-on-a-chip systems that link tumor microenvironments with immunological tissues, addressing this critical knowledge gap in vaccine development
-
University and Aarhus University Hospital, involving both Health and Science at AU. The overall project will both use an existing clinical cohort, develop the framework for a new cohort and analyse data from
-
an enthusiastic, diverse and international group of researchers. Ghent, the second largest city of Flanders, is a university city and cultural hub. Only half an hour away from Antwerp and Brussels by train, and